Navigation Links
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
Date:1/24/2012

CHENGDU, China, Jan. 24, 2012 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the Company's 2011 Annual Shareholder Meeting will be held at Floor 20, 17 State Street, New York, NY 10004 on Wednesday, April 11, 2012, at 10:00 am (EST).  

TPI's Board of Directors has established Monday, February 13, 2012, as the record date for determining the stockholders entitled to vote at the Annual Meeting.

Stockholder proposals must be received no later than Friday, February 17, 2012, in order to be considered for inclusion in the Company's proxy statement or to be presented at the Annual Meeting. Stockholder proposals should be mailed to Hunter Taubman Weiss LLP, c/o Tianyin Pharmaceutical Co., Inc, 17 State Street, Floor 20, New York, NY 10004.

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forwar
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
3. Leatt Holds 2011 Annual Meeting of Shareholders
4. IsZo Capital Writes to Taro Pharmaceutical Board Commenting on Management Proposals for 2011 Annual Shareholder Meeting; Reflecting on Sun Pharmas Response to Similar 2009 Proposals
5. Medco Shareholders Approve Merger With Express Scripts
6. Nutra Pharma Letter to Shareholders
7. GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation
8. IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders Meeting
9. Leatt Corporation Announces 2011 Annual Shareholders Meeting
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Aethlon Medical Releases Shareholder Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
(Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... therapies for cardiovascular disease and overall health is pleased to ... 2014 and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Golden Meditech Holdings Limited ("Golden Meditech" or the ... today announced that the Group has continued to increase ... Corporation ("CCBC," – CO.US) from the open market.  As ... of the issued share capital of CCBC from the ...
... SAN DIEGO, Sept. 28, 2011 Marshall Edwards, Inc. ... on the clinical development of novel therapeutics targeting cancer ... definitive agreement with its majority shareholder, Novogen Limited, to ... proceeds of $2 million, before deducting fees and expenses ...
Cached Medicine Technology:Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9% 2Marshall Edwards Announces $2 Million Private Placement 2Marshall Edwards Announces $2 Million Private Placement 3
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... KING OF PRUSSIA, Pa., Oct. 27 Universal,Health Services, ... net income was,$37.0 million, or $.73 per diluted share, ... 14% increase over the adjusted net,income per diluted share ... Net income was $152.9 million, or $3.00 per diluted ...
... Newer, more expensive drugs, rising rates of blood sugar disease ... -- The overall cost of drugs for type 2 diabetes ... drugs improve care and outcomes isn,t known, a new study ... $6.7 billion to $12.5 billion, say researchers from the University ...
... Hanger Orthopedic,Group, Inc. (NYSE: HGR ) announces ... 30, 2008, an increase of $16.4 million, or 10.1%,from ... income for,the quarter was $7.3 million, an increase of ... year. Diluted earnings per share for the,third quarter 2008 ...
... a standard ,osteoporosis therapy , , MONDAY, Oct. 27 (HealthDay ... in postmenopausal women, according to a study that followed ... mass for more than one year. , Denosumab inhibits ... women were randomly assigned to receive either a 60 ...
... Study found desires remained essentially unchanged over 3-year period ... declines in either mental or physical health, most senior ... want their end-of-life care to be when the time ... that despite observing an overall stability in patient perspective, ...
... The blood circulates through the body in an ... understand. Now, University of Missouri researcher Steven Segal ... Institute,s prestigious Method to Extend Research in Time ... signaling processes that control blood flow in the ...
Cached Medicine News:Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 2Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 3Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 4Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 5Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 6Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 7Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 8Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 9Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 10Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 11Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 12Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 13Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 14Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 15Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 16Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 17Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 18Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 19Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 20Health News:Cost of Diabetes Care Has Doubled 2Health News:Cost of Diabetes Care Has Doubled 3Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 9Health News:New Drug May Strengthen Women's Bones 2Health News:Seniors Tend to Stick With End-of-Life Care Preferences 2Health News:Seniors Tend to Stick With End-of-Life Care Preferences 3Health News:Researcher to provide new insight for treating vascular disease 2
... Titan™ Inflatable Penile Prosthesis (IPP) ... to be surgically implanted into ... of erectile dysfunction (also known ... the patient with voluntary control ...
... Positionable Penile Prosthesis,The AMS ... is made of cobalt-chrome ... strength that gives patients ... ease of positioning, cosmetic ...
... The AMS Ambicor is a uniquely designed ... of cylinders implanted in the corpora cavernosa ... the scrotum. Patients simply squeeze the pump ... deflate the prosthesis. This closed, fluid-filled system ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: